Condition: Rheumatoid Arthritis · Sponsor: Gilead Sciences
The goal of this clinical study is to learn more about the study drug GS-0151. The study is done to find how safe, well-tolerated the drug is. This will also assess how the drug is absorbed, modified, distributed and cleared from the body (the pharmacokinetics (PK) of the drug), when given multiple times to participants with rheumatoid arthritis (RA). The primary objectives of this study is to assess the safety and tolerability of multiple ascending doses of GS-0151 in participants with RA and to characterize the PK of GS-0151 following multiple doses of GS-0151 in participants with RA.
This description comes directly from the study's public registry record.
Gilead Clinical Study Information Center · 1-833-445-3230 (GILEAD-0) · GileadClinicalTrials@gilead.com
Always discuss trial participation with your own doctor first.
| Pinnacle Research Group, LLC | Anniston, Alabama, United States | Recruiting |
| University of California, San Diego | La Jolla, California, United States | Recruiting |
| Stanford University School of Medicine | Palo Alto, California, United States | Recruiting |
| Medvin Clinical Research | Tujunga, California, United States | Recruiting |
| Medvin Clinical Research | Whittier, California, United States | Recruiting |
| Clinical Research of West Florida, Inc | Clearwater, Florida, United States | Recruiting |
| Great Lakes Clinical Trials dba Flourish Research Chicago | Chicago, Illinois, United States | Recruiting |
| Accurate Clinical Research, Inc | Lake Charles, Louisiana, United States | Recruiting |
| Lynn Health Science Institute | Oklahoma City, Oklahoma, United States | Recruiting |
| Altoona Center for Clinical Research | Duncansville, Pennsylvania, United States | Recruiting |
| Accurate Clinical Management, LLC | Baytown, Texas, United States | Recruiting |
| Precision Comprehensive Clinical Research Solutions | Colleyville, Texas, United States | Recruiting |
+ 23 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06902519